Home›Companies›Healthcare›Outro Health USA

Outro Health USA Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 25, 2024·Suggest an edit

About Outro Health USA

Outro Health USA is a private company based in New York, New York, incorporated in 2022 in Delaware. It has reported $2,802,348 raised in one offering on Form D since October 2024. Its chief executive is Brandon Strain-Goode.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 31, 2024Oct 25, 2024$2,802,348of $2.8M target22$127KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Outro Health USA's Form D filed Oct 25, 2024.

BG
Brandon Strain-Goode
Chief Executive Officer and director

Sources

  1. SECOutro Health USA Inc. filing history